Xenon Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $46,542,000.

Profit Margin

Xenon Pharmaceuticals Inc. (NASDAQ:XENE): Profit margin
2014 28.37M 13.01M 45.89%
2015 15.57M -15.75M -101.12%
2016 1.80M -22.99M -1275.49%
2017 311K -30.70M -9872.67%
2018 0 -34.49M
2019 6.82M -41.59M -609.09%
2020 32.16M -28.83M -89.65%
2021 18.43M -78.88M -427.85%
2022 9.43M -125.37M -1328.95%
2023 0 -182.39M

XENE Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
09.43M18.43M32.16M6.82M0311K1.80M15.57M28.37M
Cost of revenue
167.51M105.76M75.46M50.52M38.84M6M25.57M1.11M2.76M5.90M
Gross profit
-167.51M-96.33M-57.02M-18.35M-32.01M-6M-25.26M689K12.81M22.46M
Operating exp.
Research and development
167.51M105.76M75.46M50.52M38.84M23.63M25.57M19.82M15.15M11.76M
Selling and marketing
0000000000
Total operating expenses
46.54M138.57M97.43M63.46M49.64M32.01M32.88M26.62M24.93M17.26M
Operating income
-214.05M-129.14M-78.99M-31.30M-42.81M-38.01M-32.57M-24.81M-9.36M11.10M
Other income (expenses), net
31.36M3.88M105K2.20M1.20M3.69M1.87M1.31M-6.39M1.91M
Income before tax
-182.68M-125.25M-78.88M-29.09M-41.61M-34.49M-30.70M-22.99M-15.75M13.01M
Income tax expense
292K118K-6K-257K-23K4.91M-1.87M-1.82M-1.03M0
Net income
-182.39M-125.37M-78.88M-28.83M-41.59M-34.49M-30.70M-22.99M-15.75M13.01M
Earnings per share
Basic EPS
-2.73-2.07-1.81-0.83-1.6-1.78-1.71-1.48-1.14.11
Diluted EPS
-2.73-2.07-1.81-0.83-1.6-1.78-1.71-1.48-1.13.28
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source